Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03880019
Title Olaparib and Temozolomide in Treating Patients With Advanced, Metastatic, or Unresectable Uterine Leiomyosarcoma
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital in Arizona Phoenix Arizona 85054 United States Details
Stanford Cancer Institute Palo Alto Palo Alto California 94304 United States Details
UCHealth University of Colorado Hospital Aurora Colorado 80045 United States Details
University of Florida Health Science Center - Gainesville Gainesville Florida 32610 United States Details
Mayo Clinic in Florida Jacksonville Florida 32224-9980 United States Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Weisberg Cancer Treatment Center Farmington Hills Michigan 48334 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
Virginia Commonwealth University/Massey Cancer Center Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field